首页> 外文OA文献 >The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
【2h】

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis

机译:患者和医护人员药物不良反应报告中临床信息的质量:回顾性比较分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction Clinical information is needed to assess the causal relationship between a drug and an adverse drug reaction (ADR) in a reliable way. Little is known about the level of relevant clinical information about the ADRs reported by patients. Objectives The aim was to determine to what extent patients report relevant clinical information about an ADR compared with their healthcare professional. Methods A retrospective analysis of all ADR reports on the same case, i.e., cases with a report from both the patient and the patient's healthcare professional, selected from the database of the Dutch Pharmacovigilance Center Lareb, was conducted. The extent to which relevant clinical information was reported was assessed by trained pharmacovigilance assessors, using a structured tool. The following four domains were assessed: ADR, chronology, suspected drug, and patient characteristics. For each domain, the proportion of reported information in relation to information deemed relevant was calculated. An average score of all relevant domains was determined and categorized as poorly (= 75%) reported. Data were analyzed using a paired sample t test and Wilcoxon signed rank test. Results A total of 197 cases were included. In 107 cases (54.3%), patients and healthcare professionals reported a similar level of clinical information. Statistical analysis demonstrated no overall differences between the groups (p = 0.126). Conclusions In a unique study of cases of ADRs reported by patients and healthcare professionals, we found that patients report clinical information at a similar level as their healthcare professional. For an optimal pharmacovigilance, both healthcare professionals and patient should be encouraged to report.
机译:简介需要临床信息以可靠的方式评估药物与药物不良反应(ADR)之间的因果关系。关于患者报告的有关ADR的相关临床信息水平知之甚少。目的目的是确定患者在何种程度上报告与ADR相关的临床相关信息。方法对同一病例的所有ADR报告进行回顾性分析,即从荷兰拉夫药物警戒中心的数据库中选出的患者和患者的医护人员的报告。使用结构化工具,由训练有素的药物警戒评估人员评估报告相关临床信息的程度。评估了以下四个领域:ADR,时间顺序,可疑药物和患者特征。对于每个域,计算报告的信息相对于认为相关的信息的比例。确定所有相关领域的平均得分,并将其归类为不良(= 75%)报告。使用配对样本t检验和Wilcoxon符号秩检验对数据进行分析。结果共纳入197例。在107例病例中(54.3%),患者和医护人员报告了相似的临床信息水平。统计分析表明两组之间没有总体差异(p = 0.126)。结论在一项由患者和医护人员报告的ADR病例的独特研究中,我们发现患者报告的临床信息水平与医护人员相似。为了获得最佳的药物警戒,应鼓励医疗保健专业人员和患者报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号